Amylyx Pharmaceuticals
AMLX
AMLX
170 hedge funds and large institutions have $1.08B invested in Amylyx Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+16
Holders Change %
+10.39%
% of All Funds
2.71%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
34
Increased
68
Reduced
48
Closed
16
Calls
$31.6M
Puts
$38.2M
Net Calls
-$6.69M
Net Calls Change
-$16.4M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
First Trust Advisors
Wheaton,
Illinois
| – | -$1.17M | -54,115 | Closed |
|
|
VF
177
Virtu Financial
New York
| – | -$383K | -17,742 | Closed |
|
178
Wellington Management Group
Boston,
Massachusetts
| – | -$382K | -17,716 | Closed |
|
179
Capital Fund Management (CFM)
Paris,
France
| – | -$265K | -12,281 | Closed |
|
|
BCM
180
Bayesian Capital Management
Brooklyn,
New York
| – | -$217K | -10,050 | Closed |
|
|
TAM
181
Tucker Asset Management
Littleton,
Colorado
| – | -$189K | -8,754 | Closed |
|
|
PI
182
PEAK6 Investments
Chicago,
Illinois
| – | -$32.4K | -1,500 | Closed |
|
|
CCM
183
Connective Capital Management
Palo Alto,
California
| – | -$10.1K | -466 | Closed |
|
|
QCG
184
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$108 | -5 | Closed |
|